BRENDA MERSHON: Open Payments
NPI 1710597224 · GALLIPOLIS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 43 payments from 15 companies in 2025. Trend: 2023 $467 · 2024 $906 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $265 |
| Merck Sharp & Dohme LLC | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 5 | $72 |
| Novo Nordisk Inc | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $31 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| Insulet Corporation | 1 | $20 |
| Lundbeck LLC | 1 | $16 |
Products named: QULIPTA, VRAYLAR, GARDASIL 9, JARDIANCE, Kerendia, UBRELVY, AIRSUPRA, BREZTRI.
Industry payments across OH — which companies pay providers there.
